Johnson and Johnson ordered to pay $417 million in ovarian cancer casePlay Video - 2:30
August 22nd, 2017
Johnson and Johnson ordered to pay $417 million in ovarian cancer case
In the largest verdict yet against Johnson & Johnson, a California jury awarded $417 million to a woman who claims that talc in the company’s baby powder gave her ovarian cancer. The company plans to appeal. NBC’s Joe Fryer reports on TODAY. More on this story here.